Clinical Efficacy of Remote Monitoring in the Management of Heart Failure

NCT ID: NCT01723865

Last Updated: 2014-08-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

988 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-05-31

Study Completion Date

2014-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a clinical trial to evaluate the clinical benefit of remote monitoring in patients with heart failure having an ICD-CRT implanted.

Study purpose The purpose of this study is to test the hypothesis that the monitoring of specific clinical parameters, obtained by remote controls of ICD-CRT could improve clinical course of patients with heart failure.

Study design This is a prospective observational study, comparing clinical course of patients with heart failure having an ICD-CRT implanted, followed or not by remote monitoring. This study will include 870 subjects with ICD and CRT-D, and followed by a remote monitoring system (with or without weight and pressure external sensors) or followed by conventional ambulatory visits.

Primary endpoints The primary endpoint of this study is to document no superiority of unplanned hospital access for cardiac reasons (included access to the emergency units ) or death for cardiovascular causes in remote monitoring group (with or without weight and pressure external sensors) compared to conventional follow-up (usual care group).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aim of the study The purpose of this study is to evaluate the clinical benefit of a dedicated remote monitoring system (RPM) in the management of patients with heart failure and implanted with ICDs and CRT-D.

The clinical benefit will be assessed by:

* Increased cardiovascular events (death, myocardial infarction, hospitalization).
* Events arrhythmia: atrial fibrillation, sustained and nonsustained ventricular tachycardia or ventricular fibrillation.
* Autonomic profile, echocardiographic parameters, 6-minute walk test, quality of life questionnaire.

The primary endpoint of this study is to estimate the incidence (and its accuracy) of the first event of unplanned hospitalizations for cardiac reasons or death from cardiovascular causes in the group monitored using RPM (with or without external sensors) and in the group management via conventional follow-up (Usual Care).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional

Patients with heart failure having an ICD-CRT implanted, followed by conventional visits.

No interventions assigned to this group

Remote Monitoring

Patients with heart failure having an ICD-CRT implanted, followed by remote monitoring.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects \>18 years
* patients implanted or eligible for implant with ICD-CRT-D, accordingly with guidelines of the centers, for heart failure treatment and/or primary prevention of sudden death

Exclusion Criteria

* Presence of clinically overt heart failure.
* Myocardial infarction within 2 months before enrolment.
* Significant concurrent illness or condition severely limiting life expectancy.
* Any surgical or medical condition which, at the discretion of the investigator, place the patient at higher risk from his/her participation in the study, or are likely to prevent the patient from complying with the requirements of the study or completing the trial period.
* History of drug or alcohol abuse within the last 2 years.
* Inability to communicate and comply with all study requirements including the unwillingness or inability to provide informed consent.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Effect Group, Italy

NETWORK

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gianfranco Buja, MD

Role: PRINCIPAL_INVESTIGATOR

University of Padova

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ospedali riuniti di Ancona

Ancona, , Italy

Site Status

Azienda Ospededaliero Universitaria Policlinico

Bari, , Italy

Site Status

Ospedale di Venere

Bari, , Italy

Site Status

Ospedale S.Spirito

Casale Monferrato, , Italy

Site Status

Ferrari Hospital

Casarano, , Italy

Site Status

Presidio Ospedaliero Ferrari

Castrovillari, , Italy

Site Status

Policlinico V,Emanuele - Cardiologia Ferrarotto

Catania, , Italy

Site Status

Fondazione Istituto San Raffaele G.Giglio

Cefalù, , Italy

Site Status

Dep. of Cardiology, Civic Hospital

Cirié, , Italy

Site Status

Vito Fazzi Hospital

Lecce, , Italy

Site Status

Civic Hospital

Moncalieri, , Italy

Site Status

Ospedale dei Colli - Monaldi

Napoli, , Italy

Site Status

Clinica Mediterranea

Napoli, , Italy

Site Status

Ospedale dei Colli, Monaldi

Napoli, , Italy

Site Status

Dept. Cardiology, S. Cuore Hospital

Negrar, , Italy

Site Status

Dipartimento di Scienze Cardiologiche, Toraciche e Vascolari-Università di Padova

Padua, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

References

Explore related publications, articles, or registry entries linked to this study.

Capucci A, De Simone A, Luzi M, Calvi V, Stabile G, D'Onofrio A, Maffei S, Leoni L, Morani G, Sangiuolo R, Amellone C, Checchinato C, Ammendola E, Buja G. Economic impact of remote monitoring after implantable defibrillators implantation in heart failure patients: an analysis from the EFFECT study. Europace. 2017 Sep 1;19(9):1493-1499. doi: 10.1093/europace/eux017.

Reference Type DERIVED
PMID: 28407139 (View on PubMed)

De Simone A, Leoni L, Luzi M, Amellone C, Stabile G, La Rocca V, Capucci A, D'onofrio A, Ammendola E, Accardi F, Valsecchi S, Buja G. Remote monitoring improves outcome after ICD implantation: the clinical efficacy in the management of heart failure (EFFECT) study. Europace. 2015 Aug;17(8):1267-75. doi: 10.1093/europace/euu318. Epub 2015 Apr 4.

Reference Type DERIVED
PMID: 25842271 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Effect

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CRT-P or CRT-D in Dilated Cardiomyopathy
NCT04139460 NOT_YET_RECRUITING NA